Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
Holding GPCR?
Track your performance easily

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Stock News & Sentiment

543 Followers
3 Best Stocks to Buy Now, 9/23/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 9/23/2024, According to Top Analysts 
21d ago
Structure Therapeutics Announces Key Executive Leadership Changes
Premium
Company Announcements
Structure Therapeutics Announces Key Executive Leadership Changes
27d ago
Structure Therapeutics Appoints Angus Russell to Board
Premium
Company Announcements
Structure Therapeutics Appoints Angus Russell to Board
2M ago

News Score - Last 7 Days

Neutral
GPCR
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GPCR’s Media Buzz Sentiment?
2 articles about GPCR were published this week. In an average week, 1.75 articles are published.
    What is GPCR’s weekly average amount of articles?
    In an average week, 1.75 articles about GPCR are published.
      What is GPCR’s News Sentiment?
      50% of articles about GPCR were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        ACCDAccolade
        PRCTPROCEPT BioRobotics
        SRRKScholar Rock Holding
        CLSDClearside Biomedical
        VINCVincerx Pharma Inc
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis